查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985926

北美动物实验医学市场：市场规模、份额和趋势分析（按产品、动物模型、应用、客户和国家划分），细分市场预测（2026-2033 年）

North America Laboratory Animal Medicine Market Size, Share & Trends Analysis Report By Product, By Animal Model, By Application (Rodents, Rabbits, Non-Human Primates ), By Customer, By Country, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

北美动物实验医学市场概况

北美动物实验室药物市场预计到 2025 年将达到 34 亿美元，预计到 2033 年将达到 51.8 亿美元，2026 年至 2033 年的复合年增长率为 5.48%。

市场成长的驱动因素包括：公共诊断和监测实验室网路的扩张、对动物健康研究和开发以及受监管实验室基础设施的资本投资、动物护理标准和监管要求的收紧，以及仍然依赖生物模型的应用研究领域的增长。

对动物用药品研发和监管检测设施的投资是该产业成长的关键驱动力。对生技药品生产和研发设施的大规模、多年期投资正在扩大产能，并上游工程临床前研究和验证活动。新建的研发实验室整合到製造地内，增加了製剂测试、稳定性测试和监管申报所需的体内研究量。例如，默克动物保健公司于2025年5月宣布，将投资8.95亿美元扩大其位于堪萨斯州德索託的生技药品生产设施。这些活动正在持续推动对兽医监管、健康监测和受监管动物饲养设施的需求。

在更严格的监管下，向符合良好实验室规范 (GLP) 认证的实验室过渡，进一步加速了这一成长。认证提高了对数据完整性、可追溯性和可重复性的期望，从而对与动物健康相关的变数进行更严格的控制。例如，2025 年 7 月，查克河实验室 (CRL) 成为加拿大第一个获得 GLP 认证的实验室，具备处理放射性物质和进行临床前放射性药物研究的能力。此前，加拿大标准委员会根据经合组织 (OECD) 针对加拿大卫生署和美国食品药物管理局 (FDA) 等监管机构制定的标准进行了审核。依照 GLP 标准运作的机构需要更频繁的诊断、标准化的预防保健通讯协定以及记录动物福利结果。这提高了每隻动物的医疗保健密度，而不仅仅是增加动物数量。

另一个关键的市场驱动因素是公共诊断和监测实验室网路的扩展。这一趋势正在提高实验动物医疗保健活动的规模、强度和规律性。各国政府正在建立永久性诊断系统，以进行动物疾病检测、疫苗评估和安全性研究。这提高了人们对整个实验动物群体持续健康监测、标准化诊断和有记录的兽医监管的期望。随着实验室透过正式网路合作，检测通讯协定和品质要求也日趋统一。这有助于提高每隻动物的检测频率，广泛应用确诊方法，并延长健康监测週期。动物健康数据现在不再仅在发生急性事件时才生成，而是定期生成。这种转变正在推动对诊断剂、熟练的兽医人员以及符合生物安全措施的饲养系统的需求。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：市场波动因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 价值链分析
    • 监理和伦理框架
    • 上游工程投入及相关供应商
    • 产品开发、检验和製造
    • 法规与合规
    • 分销和物流
    • 药品和生物製药的最终用户
    • 临床前试验和合约研究实验室
    • 学术和研究机构
    • 下游服务、生命週期管理与价值创造
  • 研发投资和资金筹措趋势
    • 製药和生物製药公司的内部研发投资
    • 研发领域临床前CRO的资本配置与业务运营
    • 转化研究的私人资本与资金筹措管道
    • 政策方向、伦理优先事项和资金重新分配
  • 经营模式分析
    • OEM市场进入模式
    • 直销模式与销售代理商/经销商模式
    • 捆绑式产品和服务以及长期供应合约
  • 定价分析
  • 技术与实务的趋势
    • 诊断和健康监测产品
    • 治疗药物和预防药物
    • 临床护理设备和装置
    • 临床/福利耗材
    • 其他辅助科技和作业系统
  • 客户类型与购买行为分析
    • 大製药和生技公司
    • CRO（委外研发机构）
    • 学术与研究机构、大学医院
    • 政府、国家研究机构
  • 动物实验医学在临床前试验流程中的作用
    • 临床兽医学和动物福利
    • 研究设计、手术支援和通讯协定实施
    • 设施运作、生物安全和法规遵从
    • 资料完整性、品质保证和员工培训
  • 市场分析工具
    • 波特五力分析
    • 利用SWOT分析进行PESTEL分析

第四章：北美动物实验医学市场：依产品类别分類的估算与趋势分析

  • 北美动物实验医学市场：依产品类别分類的波动分析
  • 北美动物实验医学市场估算与预测：依产品分类（2021-2033 年）
  • 诊断和健康监测产品
    • 血清及PCR检测套组
    • 微生物和寄生虫检测
    • 临床化学及血液学试剂/试剂盒
    • 其他的
  • 治疗药物和预防药物
    • 疫苗
    • 感染疾病物（抗生素、抗病毒药物、抗真菌药物）
    • 抗寄生虫药物（用于体内和体外寄生虫）
    • 止痛药和镇静剂
    • 麻醉剂
    • 抗发炎药物和支持性治疗药物
    • 其他的
  • 临床护理设备和装置
    • 动物病患监测设备
    • 麻醉机/蒸发器
    • 人工呼吸器和呼吸支持系统
    • 输液帮浦/注射式帮浦
    • 临床影像诊断设备
    • 其他的
  • 临床/福利耗材
    • 针头、注射器、导管和血管通路包。
    • 绷带、创伤护理和外科耗材
    • 消毒剂、清洁剂、卫生用品
    • 个人防护设备（PPE）、防护耗材
    • 其他的
  • 其他产品

第五章：北美动物实验医学市场：依动物模型分類的估算与趋势分析

  • 北美动物实验医学市场：以动物模型分類的波动分析
  • 北美动物实验医学市场估计与预测：按动物模型划分（2021-2033 年）
  • 囓齿动物
  • 兔子
  • 非人灵长类（NHP）
  • 其他动物

第六章：北美动物实验室医学市场：按应用分類的估算与趋势分析

  • 北美动物实验医学市场：波动分析（按应用领域划分）
  • 北美动物实验医学市场估算与预测：按应用领域划分（2021-2033 年）
    • 疾病监测，蜂群健康监测
    • 预防保健、生物安全
    • 手术全期护理（麻醉、镇痛、手术支持）
    • 慢性病管理/支持性护理
    • 福利和行为评估
    • 临终关怀，安乐死管理
    • 培训、教育和合规性支持
    • 其他的

第七章：北美动物实验医学市场：按客户群分類的估算与趋势分析

  • 北美动物实验医学市场：按客户群分類的波动分析
  • 北美动物实验医学市场估算与预测：按客户类型划分（2021-2033 年）
    • 製药和生物製药公司
    • 临床前CRO，合约检查室
    • 学术和研究机构
    • 其他的

第八章：北美动物实验医学市场：国别估算与趋势分析

  • 市场概览：按国家/地区
  • 市场占有率分析：按国家/地区划分（2025 年和 2033 年）
  • 我们
    • 主要国家的趋势
    • 竞争格局
    • 法律规范
  • 加拿大
    • 主要国家的趋势
    • 竞争格局
    • 法律规范

第九章 竞争情势

  • 参与企业的分类
    • 市场领导
    • 新兴企业
  • 市占率/估值分析（热图分析）（2025 年）
  • 公司简介
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH
    • Merck &Co., Inc.
    • Dechra
    • Elanco Animal Health
    • Kent Scientific Corporation
    • Harvard Apparatus
    • Starr
    • QIAGEN
    • Neogen Corporation
    • Mediso Ltd.
    • IITCINC
    • Thermo Fisher Scientific Inc.
    • Plas-Labs, Inc.
    • TSE Systems
    • CH Technologies（USA）, Inc
Product Code: GVR-4-68040-859-7

North America Laboratory Animal Medicine Market Summary

The North America laboratory animal medicine market size was estimated at USD 3.40 billion in 2025 and is projected to reach USD 5.18 billion by 2033, growing at a CAGR of 5.48% from 2026 to 2033. The market growth is driven by the expansion of public diagnostic and surveillance laboratory networks, capital investment in animal health R&D and regulated laboratory infrastructure, tightening animal care standards and oversight expectations, and growth in applied research areas that still depend on in vivo models.

Capital investment in animal health R&D and regulated laboratory infrastructure is one of the crucial dynamic drivers for the sector growth. Large, multi-year investments in biologics manufacturing and research facilities expand production capacity and upstream preclinical and validation activity. New R&D laboratories integrated within manufacturing campuses increase the volume of in vivo studies required for formulation testing, stability work, and regulatory submissions. For instance, in May 2025, Merck Animal Health announced USD 895 million expansion of its De Soto, Kansas, biologics manufacturing facility. Such activities are bringing sustained demand for veterinary oversight, health monitoring, and compliant animal housing.

The path towards highly regulated, GLP-certified laboratories is further amplifying this growth. Certification raises expectations for data integrity, traceability, and repeatability, thereby enabling tighter control over animal health variables. For instance, in July 2025, Chalk River Laboratories (CRL) became Canada's first GLP-certified lab capable of radioactive work and pre-clinical radiopharmaceutical studies, following a Standards Council of Canada audit that adhered to OECD standards for regulators such as Health Canada and the FDA. Facilities operating under GLP standards require more frequent diagnostics, standardized preventive care protocols, and documented welfare outcomes. This increases healthcare intensity per animal rather than depending on simple growth in animal numbers.

Another important driver for the market is the expansion of public diagnostic and surveillance laboratory networks. This dynamic has been increasing the scale, intensity, and regularity of laboratory animal healthcare activities. Governments are building permanent diagnostic capacity for detecting animal diseases, evaluating vaccines, and conducting safety investigations. This has raised expectations for continuous health monitoring, standardized diagnostics, and documented veterinary oversight across laboratory animal populations. As laboratories become connected through formal networks, testing protocols and quality requirements are becoming more uniform. This drives higher testing frequency per animal, broader use of confirmatory diagnostics, and longer health-monitoring timelines. Animal health data is now generated on a routine basis rather than only during acute events. That change increases demand for diagnostic reagents, skilled veterinary staff, and compliant animal housing systems that support biosecure operations.

North America Laboratory Animal Medicine Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the NA laboratory animal medicine market report based on product, animal model, application, customer, and country:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics & Health Surveillance Products
    • Serology & PCR Test Kits
    • Microbiology & Parasitology Assays
    • Clinical Chemistry & Hematology Reagents / Panels
    • Others
  • Therapeutics & Preventive Medicines
    • Vaccines
    • Anti-infectives (Antibiotics, Antivirals, Antifungals)
    • Antiparasitics (Endo- & Ecto-parasite Control)
    • Analgesics & Sedatives
    • Anesthetics
    • Anti-inflammatory & Supportive Care Drugs
    • Others
  • Clinical Care Devices & Equipment
    • Animal Patient Monitoring Devices
    • Anesthesia Machines & Vaporizers
    • Ventilators & Respiratory Support Systems
    • Infusion & Syringe Pumps
    • Clinical Imaging & Diagnostic Devices
    • Others
  • Clinical & Welfare Consumables
    • Needles, Syringes, Catheters & Vascular Access Sets
    • Bandages, Wound Care & Surgical Consumables
    • Disinfectants, Detergents & Sanitation Products
    • Personal Protective Equipment (PPE) & Barrier Consumables
    • Others
  • Others Products
  • Animal Model Outlook (Revenue, USD Million, 2021 - 2033)
  • Rodents
  • Rabbits
  • Non-Human Primates (NHPs)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Surveillance & Colony Health Monitoring
  • Preventive Care & Biosecurity
  • Perioperative Care (Anesthesia, Analgesia, Surgical Support)
  • Chronic Disease Management & Supportive Care
  • Welfare & Behavioral Assessment
  • End-of-Life & Euthanasia Management
  • Training, Education & Compliance Support
  • Others
  • Customer Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Preclinical CROs & Contract Laboratories
  • Academic & Research Institutions
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Model
    • 1.2.3. Application
    • 1.2.4. Customer
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Bottom-Up Analysis
    • 1.7.2. Model 2: Volume-Pricing Analysis
    • 1.7.3. Model 3: Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion Of Public Diagnostic And Surveillance Laboratory Networks
      • 3.2.1.2. Capital Investment In Animal Health R&D And Regulated Laboratory Infrastructure
      • 3.2.1.3. Strengthening Animal Care Standards And Oversight Expectations
      • 3.2.1.4. Growth In Applied Research Areas That Still Depend On In Vivo Models
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Policy Pressure To Reduce Or Replace Animal Testing
      • 3.2.2.2. Public Funding Uncertainty And Research Budget Cuts
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Value Chain Analysis
    • 3.3.1. Regulatory And Ethical Framework
    • 3.3.2. Upstream Inputs And Enabling Suppliers
    • 3.3.3. Product Development, Validation, And Manufacturing
    • 3.3.4. Regulatory And Compliance
    • 3.3.5. Distribution And Logistics
    • 3.3.6. Pharmaceutical And Biopharmaceutical End Users
    • 3.3.7. Preclinical Cros And Contract Laboratories
    • 3.3.8. Academic And Research Institutions
    • 3.3.9. Downstream Services, Lifecycle Management, And Value Capture
  • 3.4. R&D Investment & Funding Landscape
    • 3.4.1. Pharmaceutical And Biopharmaceutical Internal R&D Investment
    • 3.4.2. Preclinical Cro Capital Allocation And Operational R&D
    • 3.4.3. Private Capital And Translational Funding Pathways
    • 3.4.4. Policy Direction, Ethical Priorities, And Funding Reallocation
  • 3.5. Business Model Analysis
    • 3.5.1. OEM Go-To-Market Models
    • 3.5.2. Direct Sales Vs. Distributor / Dealer Models
    • 3.5.3. Bundled Offerings And Long-Term Supply Agreements
  • 3.6. Pricing Analysis
  • 3.7. Technology & Practice Landscape
    • 3.7.1. Diagnostics And Health Surveillance Products
    • 3.7.2. Therapeutics And Preventive Medicines
    • 3.7.3. Clinical Care Devices And Equipment
    • 3.7.4. Clinical And Welfare Consumables
    • 3.7.5. Other Supporting Technologies And Operational Systems
  • 3.8. Customer Types and Buying Behavior Analysis
    • 3.8.1. Large Pharmaceutical And Biotechnology Companies
    • 3.8.2. Contract Research Organizations (CROs)
    • 3.8.3. Academic Research Institutions And Teaching Hospitals
    • 3.8.4. Government And National Research Laboratories
  • 3.9. Role of Laboratory Animal Medicine in Preclinical Study Workflows
    • 3.9.1. Clinical Veterinary Care And Animal Welfare
    • 3.9.2. Study Design, Surgical Support, And Protocol Execution
    • 3.9.3. Facility Operations, Biosafety, And Regulatory Compliance
    • 3.9.4. Data Integrity, Quality Assurance, And Staff Training
  • 3.10. Market Analysis Tools
    • 3.10.1. Porter's Five Forces Analysis
    • 3.10.2. PESTEL by SWOT Analysis

Chapter 4. North America Laboratory Animal Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Laboratory Animal Medicine Market, By Product Movement Analysis
  • 4.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Diagnostics & Health Surveillance Products
    • 4.4.1. Diagnostics & Health Surveillance Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Serology & PCR Test Kits
      • 4.4.2.1. Serology & PCR Test Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Microbiology & Parasitology Assays
      • 4.4.3.1. Microbiology & Parasitology Assays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Clinical Chemistry & Hematology Reagents / Panels
      • 4.4.4.1. Clinical Chemistry & Hematology Reagents / Panels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Therapeutics & Preventive Medicines
    • 4.5.1. Therapeutics & Preventive Medicines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Vaccines
      • 4.5.2.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Anti-infectives (Antibiotics, Antivirals, Antifungals)
      • 4.5.3.1. Anti-infectives (Antibiotics, Antivirals, Antifungals) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Antiparasitics (Endo- & Ecto-parasite Control)
      • 4.5.4.1. Antiparasitics (Endo- & Ecto-parasite Control) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Analgesics & Sedatives
      • 4.5.5.1. Analgesics & Sedatives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Anesthetics
      • 4.5.6.1. Anesthetics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Anti-inflammatory & Supportive Care Drugs
      • 4.5.7.1. Anti-inflammatory & Supportive Care Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Others
      • 4.5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical Care Devices & Equipment
    • 4.6.1. Clinical Care Devices & Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Animal Patient Monitoring Devices
      • 4.6.2.1. Animal Patient Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Anesthesia Machines & Vaporizers
      • 4.6.3.1. Anesthesia Machines & Vaporizers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Ventilators & Respiratory Support Systems
      • 4.6.4.1. Ventilators & Respiratory Support Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Infusion & Syringe Pumps
      • 4.6.5.1. Infusion & Syringe Pumps Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.6. Clinical Imaging & Diagnostic Devices
      • 4.6.6.1. Clinical Imaging & Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.7. Others
      • 4.6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Clinical & Welfare Consumables
    • 4.7.1. Clinical & Welfare Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Needles, Syringes, Catheters & Vascular Access Sets
      • 4.7.2.1. Needles, Syringes, Catheters & Vascular Access Sets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Bandages, Wound Care & Surgical Consumables
      • 4.7.3.1. Bandages, Wound Care & Surgical Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Disinfectants, Detergents & Sanitation Products
      • 4.7.4.1. Disinfectants, Detergents & Sanitation Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Personal Protective Equipment (PPE) & Barrier Consumables
      • 4.7.5.1. Personal Protective Equipment (PPE) & Barrier Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.6. Others
      • 4.7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Products
    • 4.8.1. Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Laboratory Animal Medicine Market: Animal Model Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Laboratory Animal Medicine Market, By Animal Model Movement Analysis
  • 5.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Animal Model, 2021 to 2033 (USD Million)
  • 5.4. Rodents
    • 5.4.1. Rodents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Rabbits
    • 5.5.1. Rabbits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Non-Human Primates (NHPs)
    • 5.6.1. Non-Human Primates (NHPs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others Animals
    • 5.7.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Laboratory Animal Medicine Market: By Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America Laboratory Animal Medicine Market, By Application Movement Analysis
  • 6.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, By Application, 2021 to 2033 (USD Million)
    • 6.3.1. Disease Surveillance & Colony Health Monitoring
      • 6.3.1.1. Disease Surveillance & Colony Health Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Preventive Care & Biosecurity
      • 6.3.2.1. Preventive Care & Biosecurity Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Perioperative Care (Anesthesia, Analgesia, Surgical Support)
      • 6.3.3.1. Perioperative Care (Anesthesia, Analgesia, Surgical Support) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Chronic Disease Management & Supportive Care
      • 6.3.4.1. Chronic Disease Management & Supportive Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Welfare & Behavioral Assessment
      • 6.3.5.1. Welfare & Behavioral Assessment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. End-of-Life & Euthanasia Management
      • 6.3.6.1. End-of-Life & Euthanasia Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Training, Education & Compliance Support
      • 6.3.7.1. Training, Education & Compliance Support Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Others
      • 6.3.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America Laboratory Animal Medicine Market: By Customer Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America Laboratory Animal Medicine Market, By Customer Movement Analysis
  • 7.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Customer, 2021 to 2033 (USD Million)
    • 7.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 7.3.1.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Preclinical CROs & Contract Laboratories
      • 7.3.2.1. Preclinical CROs & Contract Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Academic & Research Institutions
      • 7.3.3.1. Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America Laboratory Animal Medicine Market: By Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market Share Analysis, 2025 & 2033
  • 8.3. U.S
    • 8.3.1. Key Country Dynamics
    • 8.3.2. Competitive Scenario
    • 8.3.3. Regulatory Framework
    • 8.3.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key Country Dynamics
    • 8.4.2. Competitive Scenario
    • 8.4.3. Regulatory Framework
    • 8.4.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis Services LLC
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Boehringer Ingelheim International GmbH
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Merck & Co., Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Dechra
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Elanco Animal Health
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Kent Scientific Corporation
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Harvard Apparatus
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Starr
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. QIAGEN
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Neogen Corporation
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Mediso Ltd.
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. IITCINC
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Thermo Fisher Scientific Inc.
      • 9.3.13.1. Participant's Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Plas-Labs, Inc.
      • 9.3.14.1. Participant's Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. TSE Systems
      • 9.3.15.1. Participant's Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. CH Technologies (USA), Inc
      • 9.3.16.1. Participant's Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product Benchmarking
      • 9.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Laboratory Animal Medicine Market, By Country, 2021 - 203 (USD Million)
  • Table 4 U.S. Laboratory Animal Medicine Market, By Product, 2021 - 203 (USD Million)
  • Table 5 U.S. Laboratory Animal Medicine Market, By Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Table 6 U.S. Laboratory Animal Medicine Market, By Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Table 7 U.S. Laboratory Animal Medicine Market, By Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Table 8 U.S. Laboratory Animal Medicine Market, By Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Table 9 U.S. Laboratory Animal Medicine Market, By Animal Model, 2021 - 203 (USD Million)
  • Table 10 U.S. Laboratory Animal Medicine Market, By Application, 2021 - 203 (USD Million)
  • Table 11 U.S. Laboratory Animal Medicine Market, By Customer, 2021 - 203 (USD Million)
  • Table 12 Canada Laboratory Animal Medicine Market, By Product, 2021 - 203 (USD Million)
  • Table 13 Canada Laboratory Animal Medicine Market, By Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Table 14 Canada Laboratory Animal Medicine Market, By Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Table 15 Canada Laboratory Animal Medicine Market, By Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Table 16 Canada Laboratory Animal Medicine Market, By Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Table 17 Canada Laboratory Animal Medicine Market, By Animal Model, 2021 - 203 (USD Million)
  • Table 18 Canada Laboratory Animal Medicine Market, By Application, 2021 - 203 (USD Million)
  • Table 19 Canada Laboratory Animal Medicine Market, By Customer, 2021 - 203 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 North America Laboratory Animal Medicine Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Country Marketplace: Key Takeaways
  • Fig. 14 North America Laboratory Animal Medicine Market, for Product, 2021 - 203 (USD Million)
  • Fig. 15 North America Laboratory Animal Medicine Market, for Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Fig. 16 North America Laboratory Animal Medicine Market, for Serology & PCR Test Kits , 2021 - 203 (USD Million)
  • Fig. 17 North America Laboratory Animal Medicine Market, for Microbiology & Parasitology Assays , 2021 - 203 (USD Million)
  • Fig. 18 North America Laboratory Animal Medicine Market, for Clinical Chemistry & Hematology Reagents / Panels , 2021 - 203 (USD Million)
  • Fig. 19 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 20 North America Laboratory Animal Medicine Market, for Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Fig. 21 North America Laboratory Animal Medicine Market, for Vaccines , 2021 - 203 (USD Million)
  • Fig. 22 North America Laboratory Animal Medicine Market, for Anti-infectives (Antibiotics, Antivirals, Antifungals) , 2021 - 203 (USD Million)
  • Fig. 23 North America Laboratory Animal Medicine Market, for Antiparasitics (Endo- & Ecto-parasite Control) , 2021 - 203 (USD Million)
  • Fig. 24 North America Laboratory Animal Medicine Market, for Analgesics & Sedatives , 2021 - 203 (USD Million)
  • Fig. 25 North America Laboratory Animal Medicine Market, for Anesthetics , 2021 - 203 (USD Million)
  • Fig. 26 North America Laboratory Animal Medicine Market, for Anti-inflammatory & Supportive Care Drugs , 2021 - 203 (USD Million)
  • Fig. 27 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 28 North America Laboratory Animal Medicine Market, for Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Fig. 29 North America Laboratory Animal Medicine Market, for Animal Patient Monitoring Devices , 2021 - 203 (USD Million)
  • Fig. 30 North America Laboratory Animal Medicine Market, for Anesthesia Machines & Vaporizers , 2021 - 203 (USD Million)
  • Fig. 31 North America Laboratory Animal Medicine Market, for Ventilators & Respiratory Support Systems , 2021 - 203 (USD Million)
  • Fig. 32 North America Laboratory Animal Medicine Market, for Infusion & Syringe Pumps , 2021 - 203 (USD Million)
  • Fig. 33 North America Laboratory Animal Medicine Market, for Clinical Imaging & Diagnostic Devices , 2021 - 203 (USD Million)
  • Fig. 34 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 35 North America Laboratory Animal Medicine Market, for Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Fig. 36 North America Laboratory Animal Medicine Market, for Needles, Syringes, Catheters & Vascular Access Sets , 2021 - 203 (USD Million)
  • Fig. 37 North America Laboratory Animal Medicine Market, for Bandages, Wound Care & Surgical Consumables , 2021 - 203 (USD Million)
  • Fig. 38 North America Laboratory Animal Medicine Market, for Disinfectants, Detergents & Sanitation Products , 2021 - 203 (USD Million)
  • Fig. 39 North America Laboratory Animal Medicine Market, for Personal Protective Equipment (PPE) & Barrier Consumables, 2021 - 203 (USD Million)
  • Fig. 40 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 41 North America Laboratory Animal Medicine Market, for Others, 2021 - 203 (USD Million)
  • Fig. 42 North America Laboratory Animal Medicine Market, for Animal Model, 2021 - 203 (USD Million)
  • Fig. 43 North America Laboratory Animal Medicine Market, for Rodents , 2021 - 203 (USD Million)
  • Fig. 44 North America Laboratory Animal Medicine Market, for Rabbits , 2021 - 203 (USD Million)
  • Fig. 45 North America Laboratory Animal Medicine Market, for Non-Human Primates , 2021 - 203 (USD Million)
  • Fig. 46 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 47 North America Laboratory Animal Medicine Market, for Application, 2021 - 203 (USD Million)
  • Fig. 48 North America Laboratory Animal Medicine Market, for Disease Surveillance & Colony Health Monitoring , 2021 - 203 (USD Million)
  • Fig. 49 North America Laboratory Animal Medicine Market, for Preventive Care & Biosecurity , 2021 - 203 (USD Million)
  • Fig. 50 North America Laboratory Animal Medicine Market, for Perioperative Care (Anesthesia, Analgesia, Surgical Support) , 2021 - 203 (USD Million)
  • Fig. 51 North America Laboratory Animal Medicine Market, for Chronic Disease Management & Supportive Care 2021 - 203 (USD Million)
  • Fig. 52 North America Laboratory Animal Medicine Market, for Welfare & Behavioral Assessment 2021 - 203 (USD Million)
  • Fig. 53 North America Laboratory Animal Medicine Market, for End-of-Life & Euthanasia Management 2021 - 203 (USD Million)
  • Fig. 54 North America Laboratory Animal Medicine Market, for Training, Education & Compliance Support 2021 - 203 (USD Million)
  • Fig. 55 North America Laboratory Animal Medicine Market, for Others 2021 - 203 (USD Million)
  • Fig. 56 North America Laboratory Animal Medicine Market, for Customer type 2021 - 203 (USD Million)
  • Fig. 57 North America Laboratory Animal Medicine Market, for Pharmaceutical & Biopharmaceutical Companies 2021 - 203 (USD Million)
  • Fig. 58 North America Laboratory Animal Medicine Market, for Preclinical CROs & Contract Laboratories 2021 - 203 (USD Million)
  • Fig. 59 North America Laboratory Animal Medicine Market, for Academic & Research Institutions 2021 - 203 (USD Million)
  • Fig. 60 North America Laboratory Animal Medicine Market, for Others 2021 - 203 (USD Million)
  • Fig. 61 U.S. Laboratory Animal Medicine Market, 2021 - 203 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Canada Laboratory Animal Medicine Market, 2021 - 203 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Key Company Categorization
  • Fig. 66 Heat Map Analysis
  • Fig. 67 Strategic Framework